- Home
- Publications
- Publication Search
- Publication Details
Title
The miRNAs Role in Melanoma and in Its Resistance to Therapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 3, Pages 878
Publisher
MDPI AG
Online
2020-01-29
DOI
10.3390/ijms21030878
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Demethylation by low-dose 5-aza-2′-deoxycytidine impairs 3D melanoma invasion partially through miR-199a-3p expression revealing the role of this miR in melanoma
- (2019) Cécile Desjobert et al. Clinical Epigenetics
- miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma
- (2019) Jianchang Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- miR-145-5p inhibits tumor occurrence and metastasis through the NF-κB signaling pathway by targeting TLR4 in malignant melanoma
- (2019) Canhui Jin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MiR-150-5p regulates melanoma proliferation, invasion and metastasis via SIX1-mediated Warburg Effect
- (2019) Xuhui Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Many ways to resistance: How melanoma cells evade targeted therapies
- (2019) Ines Kozar et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- miR-10b promoted melanoma progression through Wnt/β-catenin pathway by repressing ITCH expression
- (2019) Shengqiang Wang et al. GENE
- MicroRNA‐203 reinforces stemness properties in melanoma and augments tumorigenesis in vivo
- (2019) Parisa Sahranavardfard et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing
- (2019) Parvez M. Lokhandwala et al. BMC CANCER
- microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1
- (2019) Hui Wang et al. BMC CANCER
- MicroRNA-429 inhibits cancer cell proliferation and migration by targeting the AKT1 in melanoma
- (2019) Deshun Huang et al. Cancer Biomarkers
- miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
- (2019) Simona Caporali et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Combination of CTLA-4 and PD-1 blockers for treatment of cancer
- (2019) Anand Rotte JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma
- (2019) Antoni Ribas et al. NATURE MEDICINE
- Adipocytes sensitize melanoma cells to environmental TGF-β cues by repressing the expression of miR-211
- (2019) Tamar Golan et al. Science Signaling
- MicroRNA‑338‑3p suppresses cell proliferation, migration and invasion in human malignant melanoma by targeting MACC1
- (2019) Chunhua Zhang et al. Experimental and Therapeutic Medicine
- MicroRNA-138 negatively regulates the hypoxia-inducible factor 1α to suppress melanoma growth and metastasis
- (2019) Haijiang Qiu et al. Biology Open
- miR-30b-5p acts as a tumor suppressor microRNA in esophageal squamous cell carcinoma
- (2019) Jianfeng Xu et al. Journal of Thoracic Disease
- Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal Effect
- (2019) Nathan Suek et al. Frontiers in Immunology
- MicroRNA Ratios Distinguish Melanomas from Nevi
- (2019) Rodrigo Torres et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Sensitive Detection and Analysis of Neoantigen-Specific T Cell Populations from Tumors and Blood
- (2019) Songming Peng et al. Cell Reports
- Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma
- (2019) Inna Smalley et al. EBioMedicine
- The miR-31-SOX10 axis regulates tumor growth and chemotherapy resistance of melanoma via PI3K/AKT pathway
- (2018) Ying Zheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells
- (2018) Yuxia Li et al. BMC CANCER
- Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E
- (2018) Yongbo Song et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers
- (2018) Jaquelyn N. Sanchez et al. DRUGS
- Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis
- (2018) Warangkana Lohcharoenkal et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- MicroRNA-542-3p suppresses tumor cell proliferation via targeting Smad2 inhuman osteosarcoma
- (2018) Yinsheng Wu et al. Oncology Letters
- miR-128 inhibits telomerase activity by targeting TERT mRNA
- (2018) Herlinda Guzman et al. Oncotarget
- Genetic alterations in main candidate genes during melanoma progression
- (2018) Maria Cristina Sini et al. Oncotarget
- Key questions about the checkpoint blockade-are microRNAs an answer?
- (2018) Dragomir Mihnea et al. Cancer Biology & Medicine
- Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma
- (2018) Luigi Fattore et al. CELL DEATH AND DIFFERENTIATION
- Clinical and Biological Characterization of Skin Pigmentation Diversity and Its Consequences on UV Impact
- (2018) Sandra Del Bino et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/β-catenin positive feedback loop
- (2018) Tingting Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MicroRNA‑373 promotes cell migration via targeting salt‑inducible kinase 1 expression in melanoma
- (2018) Xinping Bai et al. Experimental and Therapeutic Medicine
- Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches
- (2018) Giuseppe Palmieri et al. Current Oncology Reports
- miR-193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro
- (2018) Theresa Kordaß et al. Oncotarget
- miR-146a Controls Immune Response in the Melanoma Microenvironment
- (2018) Justin Mastroianni et al. CANCER RESEARCH
- Advanced stage melanoma therapies: Detailing the present and exploring the future
- (2018) Chelsea Luther et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Mechanism of miR-137 regulating migration and invasion of melanoma cells by targeting PIK3R3 gene
- (2018) Jia Qi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma
- (2018) Veronica Huber et al. JOURNAL OF CLINICAL INVESTIGATION
- Melanoma subtypes: Genomic profiles, prognostic molecular markers and therapeutic possibilities
- (2018) Roy Rabbie et al. JOURNAL OF PATHOLOGY
- Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
- (2018) Frank Stephen Hodi et al. LANCET ONCOLOGY
- miR-25 Promotes Melanoma Progression by regulating RNA binding motif protein 47
- (2018) Qun-Qun Jiang et al. M S-MEDECINE SCIENCES
- Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
- (2018) Rodabe N. Amaria et al. NATURE MEDICINE
- MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation
- (2018) Praveen K. Bommareddy et al. Science Translational Medicine
- Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma
- (2018) Sunilkumar Kakadia et al. OncoTargets and Therapy
- New insights in melanoma resistance to BRAF inhibitors: a role for microRNAs
- (2018) Marta Díaz-Martínez et al. Oncotarget
- MiR-542-3p, a microRNA targeting CDK14, suppresses cell proliferation, invasiveness, and tumorigenesis of epithelial ovarian cancer
- (2018) Jingwei Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Vitamin D status and risk for malignant cutaneous melanoma
- (2017) Maria N. Ombra et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Somatic mutation analysis in melanoma using targeted next generation sequencing
- (2017) Allen P. Miraflor et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma
- (2017) Matias A. Bustos et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape
- (2017) Stefan B. Eichmüller et al. JNCI-Journal of the National Cancer Institute
- MicroRNA-605 functions as a tumor suppressor by targeting INPP4B in melanoma
- (2017) Lan Chen et al. ONCOLOGY REPORTS
- Phenotype characterization of human melanoma cells resistant to dabrafenib
- (2017) Fabiola Gilda Cordaro et al. ONCOLOGY REPORTS
- MicroRNA-125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway
- (2017) Lisa Koetz-Ploch et al. Pigment Cell & Melanoma Research
- PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p
- (2017) Valentina Audrito et al. Oncotarget
- MicroRNAs in melanoma development and resistance to target therapy
- (2017) Luigi Fattore et al. Oncotarget
- MicroRNAs with prognostic significance in osteosarcoma: a systemic review and meta-analysis
- (2017) Dong Cheng et al. Oncotarget
- Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines
- (2017) Bradley Garman et al. Cell Reports
- Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape
- (2017) Stefan B. Eichmüller et al. JNCI-Journal of the National Cancer Institute
- Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines
- (2017) Ken Noguchi et al. PLoS One
- MITF and BRN2 contribute to metastatic growth after dissemination of melanoma
- (2017) Jacinta L. Simmons et al. Scientific Reports
- miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase, PIM1, in melanoma
- (2016) Zhen Rang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Upregulation of miR-124 by physcion 8- O -β-glucopyranoside inhibits proliferation and invasion of malignant melanoma cells via repressing RLIP76
- (2016) Di Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer
- (2016) Yusuke Goto et al. BRITISH JOURNAL OF CANCER
- Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: a case report from a phase III trial
- (2016) Paolo A. Ascierto et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- miR-339-3p Is a Tumor Suppressor in Melanoma
- (2016) C. E. M. Weber et al. CANCER RESEARCH
- Biomarker value and pitfalls of serum S100B in the follow-up of high-risk melanoma patients
- (2016) Christoffer Gebhardt et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Regulation of Melanoma Progression through the TCF4/miR-125b/NEDD9 Cascade
- (2016) Florian Rambow et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma
- (2016) Federica Felicetti et al. Journal of Translational Medicine
- MicroRNA-21 expression and its pathogenetic significance in cutaneous melanoma
- (2016) Gerald Saldanha et al. MELANOMA RESEARCH
- miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
- (2016) M. Raimo et al. MOLECULAR CANCER RESEARCH
- miR-194 is a negative regulator of GEF-H1 pathway in melanoma
- (2016) Bingyu Guo et al. ONCOLOGY REPORTS
- miR-579-3p controls melanoma progression and resistance to target therapy
- (2016) Luigi Fattore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-138 suppresses proliferation, invasion and glycolysis in malignant melanoma cells by targeting HIF-1α
- (2016) YAO CHEN et al. Experimental and Therapeutic Medicine
- miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways
- (2016) Xiaoyan Sun et al. Oncotarget
- Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22
- (2016) Wenkang Luan et al. Oncotarget
- miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion
- (2016) Qing Li et al. Oncotarget
- Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma
- (2016) Marcel A. Deken et al. OncoImmunology
- microRNA Therapeutics in Cancer — An Emerging Concept
- (2016) Maitri Y. Shah et al. EBioMedicine
- Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports
- (2016) Noha Abdel-Wahab et al. PLoS One
- miR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways That Drive Tumour Progression and Metastasis
- (2016) S. J. Seashols-Williams et al. PLoS One
- Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy
- (2016) Prasun J. Mishra et al. PLoS One
- In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
- (2015) Yunching Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- miR-203 inhibits melanoma invasive and proliferative abilities by targeting the polycomb group gene BMI1
- (2015) Xiao Chang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Telmisartan attenuates the inflamed mesenteric adipose tissue in spontaneous colitis by mechanisms involving regulation of neurotensin/microRNA-155 pathway
- (2015) Yi Li et al. BIOCHEMICAL PHARMACOLOGY
- MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression
- (2015) Juanjuan Bai et al. Cancer Biomarkers
- Lin28B promotes melanoma growth by mediating a microRNA regulatory circuit
- (2015) Zhenfeng Zhang et al. CARCINOGENESIS
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- MITF Modulates Therapeutic Resistance through EGFR Signaling
- (2015) Zhenyu Ji et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Progression of mouse skin carcinogenesis is associated with the orchestrated deregulation of mir-200 family members, mir-205 and their common targets
- (2015) Elena Skourti et al. MOLECULAR CARCINOGENESIS
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment
- (2015) Shujing Liu et al. Pigment Cell & Melanoma Research
- MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer
- (2015) Shu-Bo Tian WORLD JOURNAL OF GASTROENTEROLOGY
- MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET
- (2015) Y-Q Li et al. Cell Death & Disease
- Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer?
- (2015) Christiane Margue et al. Oncotarget
- Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
- (2015) Elisabetta Vergani et al. Oncotarget
- MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1
- (2015) Dong-dong Cheng et al. Oncotarget
- miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1
- (2015) Ronit Cohen et al. Oncotarget
- miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy
- (2015) Animesh Bhattacharya et al. Oncotarget
- miR-19b regulates hTERT mRNA expression through targeting PITX1 mRNA in melanoma cells
- (2015) Takahito Ohira et al. Scientific Reports
- MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603
- (2015) Liza C. Villaruz et al. Clinical Epigenetics
- Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma
- (2015) Blanca Homet Moreno et al. OncoImmunology
- The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis
- (2015) Mitchell S. Stark et al. EBioMedicine
- MiR-21 Enhances Melanoma Invasiveness via Inhibition of Tissue Inhibitor of Metalloproteinases 3 Expression: In Vivo Effects of MiR-21 Inhibitor
- (2015) Sara E. Martin del Campo et al. PLoS One
- microRNA-155, Induced by Interleukin-1ß, Represses the Expression of Microphthalmia-Associated Transcription Factor (MITF-M) in Melanoma Cells
- (2015) Nathalie Arts et al. PLoS One
- Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness
- (2015) Helge Siemens et al. Oncotarget
- Pathways and therapeutic targets in melanoma
- (2015) Emma Shtivelman et al. Oncotarget
- miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2
- (2015) Szu-Mam Liu et al. Oncotarget
- Evaluating biomarkers in melanoma
- (2015) Panagiotis Karagiannis et al. Frontiers in Oncology
- Good guy or bad guy: the opposing roles of microRNA 125b in cancer
- (2014) Julia Banzhaf-Strathmann et al. Cell Communication and Signaling
- E2F1 induces miR-224/452 expression to drive EMT through TXNIP downregulation
- (2014) S. Knoll et al. EMBO REPORTS
- Analysis of the BRAF V600E mutation in primary cutaneous melanoma
- (2014) J.S.S. Inumaru et al. GENETICS AND MOLECULAR RESEARCH
- MicroRNA-340-mediated Degradation of Microphthalmia-associated Transcription Factor (MITF) mRNA Is Inhibited by Coding Region Determinant-binding Protein (CRD-BP)
- (2014) Srikanta Goswami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Meta-analysis of Somatic Mutations from Next Generation Sequencing of 241 Melanomas: A Road Map for the Study of Genes with Potential Clinical Relevance
- (2014) J. Xia et al. MOLECULAR CANCER THERAPEUTICS
- The validity of circulating microRNAs in oncology: Five years of challenges and contradictions
- (2014) J. Jarry et al. Molecular Oncology
- MicroRNA-218 inhibits melanogenesis by directly suppressing microphthalmia-associated transcription factor expression
- (2014) Jia Guo et al. RNA Biology
- Expression patterns of microRNA-218 and its potential functions by targeting CIP2A and BMI1 genes in melanoma
- (2014) Yanping Wei et al. TUMOR BIOLOGY
- Running for time: circadian rhythms and melanoma
- (2014) Elitza P. Markova-Car et al. TUMOR BIOLOGY
- Analysis of microRNA-203 function in CREB/MITF/RAB27a pathway: comparison between canine and human melanoma cells
- (2014) S. Noguchi et al. Veterinary and Comparative Oncology
- miR-146a promotes the initiation and progression of melanoma by activating Notch signaling
- (2014) Matteo Forloni et al. eLife
- MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2
- (2013) Chonglin Luo et al. CANCER LETTERS
- miR-205 Targets PTEN and PHLPP2 to Augment AKT Signaling and Drive Malignant Phenotypes in Non-Small Cell Lung Cancer
- (2013) J. Cai et al. CANCER RESEARCH
- MiR-30d induces apoptosis and is regulated by the Akt/FOXO pathway in renal cell carcinoma
- (2013) Chenglin Wu et al. CELLULAR SIGNALLING
- Resistance to BRAF-targeted therapy in melanoma
- (2013) Ryan J. Sullivan et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1
- (2013) Wenxing Qin et al. FEBS LETTERS
- Transcription Factor/microRNA Axis Blocks Melanoma Invasion Program by miR-211 Targeting NUAK1
- (2013) Rachel E. Bell et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression
- (2013) Altaf A Dar et al. JNCI-Journal of the National Cancer Institute
- MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and Bevacizumab
- (2013) Aubrey G Wagenseller et al. Journal of Translational Medicine
- New Target Genes of MITF-Induced microRNA-211 Contribute to Melanoma Cell Invasion
- (2013) Christiane Margue et al. PLoS One
- miR-200c Inhibits Melanoma Progression and Drug Resistance through Down-Regulation of Bmi-1
- (2012) Shujing Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors
- (2012) Y Xu et al. BRITISH JOURNAL OF CANCER
- Hypoxia-Inducible miR-210 Regulates the Susceptibility of Tumor Cells to Lysis by Cytotoxic T Cells
- (2012) M. Z. Noman et al. CANCER RESEARCH
- MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy
- (2012) M. F. Segura et al. CARCINOGENESIS
- Convergent Multi-miRNA Targeting of ApoE Drives LRP1/LRP8-Dependent Melanoma Metastasis and Angiogenesis
- (2012) Nora Pencheva et al. CELL
- MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN
- (2012) Changju Qu et al. CELL CYCLE
- Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)
- (2012) ALESSANDRO ALLEGRA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- BRAF/NRASMutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
- (2012) Maria Colombino et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA-494 Is Required for the Accumulation and Functions of Tumor-Expanded Myeloid-Derived Suppressor Cells via Targeting of PTEN
- (2012) Y. Liu et al. JOURNAL OF IMMUNOLOGY
- MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression
- (2012) M Kappelmann et al. ONCOGENE
- Driver Mutations in Melanoma: Lessons Learned From Bench-to-Bedside Studies
- (2012) Janice M. Mehnert et al. Current Oncology Reports
- miR-30b/30d Regulation of GalNAc Transferases Enhances Invasion and Immunosuppression during Metastasis
- (2011) Avital Gaziel-Sovran et al. CANCER CELL
- Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D
- (2011) A. Heinemann et al. CANCER RESEARCH
- miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy
- (2011) M. Garofalo et al. CURRENT MOLECULAR MEDICINE
- microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C
- (2011) Elisa Penna et al. EMBO JOURNAL
- MicroRNA miR-21 Regulates the Metastatic Behavior of B16 Melanoma Cells
- (2011) Chuan He Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 Protein
- (2011) Altaf A. Dar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prognostic and Clinicopathologic Associations of OncogenicBRAFin Metastatic Melanoma
- (2011) Georgina V. Long et al. JOURNAL OF CLINICAL ONCOLOGY
- The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker
- (2011) Hisashi Kanemaru et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma
- (2011) Shujing Liu et al. JOURNAL OF PATHOLOGY
- Comparative Study of Anti-Oncogenic MicroRNA-145 in Canine and Human Malignant Melanoma
- (2011) Shunsuke NOGUCHI et al. JOURNAL OF VETERINARY MEDICAL SCIENCE
- A picture of Mitf in melanoma immortality
- (2011) C R Goding ONCOGENE
- MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A
- (2011) XIAO YUE et al. ONCOLOGY REPORTS
- Generation of melanocytes from neural crest cells
- (2011) Lukas Sommer Pigment Cell & Melanoma Research
- MicroRNA-155 targets the SKI gene in human melanoma cell lines
- (2011) Lauretta Levati et al. Pigment Cell & Melanoma Research
- Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor
- (2011) Glen M. Boyle et al. Pigment Cell & Melanoma Research
- MicroRNA-193b Represses Cell Proliferation and Regulates Cyclin D1 in Melanoma
- (2010) Jiamin Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- Advances in systemic treatment of melanoma
- (2010) A. M. M. Eggermont ANNALS OF ONCOLOGY
- High-throughput miRNA profiling of human melanoma blood samples
- (2010) Petra Leidinger et al. BMC CANCER
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Survival in Patients with Metastatic Melanoma Treated with DTIC or Temozolomide
- (2010) C. Kim et al. ONCOLOGIST
- Mouse melanoma models and cell lines
- (2010) William E. Damsky Jr et al. Pigment Cell & Melanoma Research
- miR-148 Regulates Mitf in Melanoma Cells
- (2010) Benedikta S. Haflidadóttir et al. PLoS One
- Role of radiotherapy in melanoma management
- (2010) Primoz Strojan Radiology and Oncology
- miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase C
- (2009) P. Gandellini et al. CANCER RESEARCH
- Suppression of cell growth and invasion by miR-205 in breast cancer
- (2009) Hailong Wu et al. CELL RESEARCH
- Regulation of RUNX3 Tumor Suppressor Gene Expression in Cutaneous Melanoma
- (2009) M. Kitago et al. CLINICAL CANCER RESEARCH
- MicroRNAs: Novel Biomarkers for Human Cancer
- (2009) C. L. Bartels et al. CLINICAL CHEMISTRY
- Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer
- (2009) Guilherme Rabinowits et al. Clinical Lung Cancer
- MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases
- (2009) Maria Angelica Cortez et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor
- (2009) Miguel F. Segura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- p53 represses c-Myc through induction of the tumor suppressor miR-145
- (2009) M. Sachdeva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-137 Targets Microphthalmia-Associated Transcription Factor in Melanoma Cell Lines
- (2008) L. T. Bemis et al. CANCER RESEARCH
- MicroRNAs Impair MET-Mediated Invasive Growth
- (2008) C. Migliore et al. CANCER RESEARCH
- The Promyelocytic Leukemia Zinc Finger-MicroRNA-221/-222 Pathway Controls Melanoma Progression through Multiple Oncogenic Mechanisms
- (2008) F. Felicetti et al. CANCER RESEARCH
- Brn-2 Represses Microphthalmia-Associated Transcription Factor Expression and Marks a Distinct Subpopulation of Microphthalmia-Associated Transcription Factor-Negative Melanoma Cells
- (2008) J. Goodall et al. CANCER RESEARCH
- MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth
- (2008) Julia Schultz et al. CELL RESEARCH
- Integrin β3 expression is regulated by let-7a miRNA in malignant melanoma
- (2008) D W Müller et al. ONCOGENE
- Novel MITF targets identified using a two-step DNA microarray strategy
- (2008) Keith S. Hoek et al. Pigment Cell & Melanoma Research
- The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice
- (2008) Neri Mercatelli et al. PLoS One
- Melanoma and the tumor microenvironment
- (2008) Jessie Villanueva et al. Current Oncology Reports
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started